GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » E10

Addex Therapeutics (XSWX:ADXN) E10 : CHF-2.34 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Addex Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was CHF-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is CHF-2.34 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-08), Addex Therapeutics's current stock price is CHF0.062. Addex Therapeutics's E10 for the quarter that ended in Mar. 2024 was CHF-2.34. Addex Therapeutics's Shiller PE Ratio of today is .


Addex Therapeutics E10 Historical Data

The historical data trend for Addex Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics E10 Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -2.68

Addex Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.82 -2.75 -2.68 -2.34

Competitive Comparison of Addex Therapeutics's E10

For the Biotechnology subindustry, Addex Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Shiller PE Ratio falls into.



Addex Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Addex Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.03/107.3549*107.3549
=-0.030

Current CPI (Mar. 2024) = 107.3549.

Addex Therapeutics Quarterly Data

per share eps CPI Adj_EPS
200912 -4.020 101.610 -4.247
201006 -3.010 102.102 -3.165
201012 -2.680 102.138 -2.817
201106 -2.070 102.678 -2.164
201112 -2.120 101.408 -2.244
201206 -1.930 101.596 -2.039
201212 -1.430 100.968 -1.520
201306 -1.610 101.466 -1.703
201312 0.010 101.036 0.011
201406 -0.100 101.517 -0.106
201412 -0.080 100.704 -0.085
201506 -0.260 100.464 -0.278
201512 -0.130 99.386 -0.140
201606 -0.130 100.088 -0.139
201612 -0.150 99.380 -0.162
201706 -0.140 100.285 -0.150
201712 -0.110 100.213 -0.118
201806 0.100 101.435 0.106
201812 -0.190 100.906 -0.202
201903 -0.120 101.571 -0.127
201906 -0.170 102.044 -0.179
201909 -0.140 101.396 -0.148
201912 -0.140 101.063 -0.149
202003 -0.160 101.048 -0.170
202006 -0.120 100.743 -0.128
202009 -0.120 100.585 -0.128
202012 -0.080 100.241 -0.086
202103 -0.080 100.800 -0.085
202106 -0.140 101.352 -0.148
202109 -0.110 101.533 -0.116
202112 -0.130 101.776 -0.137
202203 -0.150 103.205 -0.156
202206 -0.190 104.783 -0.195
202209 -0.090 104.835 -0.092
202212 -0.040 104.666 -0.041
202303 -0.040 106.245 -0.040
202306 -0.040 106.576 -0.040
202309 -0.030 106.570 -0.030
202312 -0.030 106.461 -0.030
202403 -0.030 107.355 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


Addex Therapeutics  (XSWX:ADXN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Addex Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (XSWX:ADXN) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021